SCHEMBL7215895

SCHEMBL7215895

O=C(O)C1=Cc2cc(OCc3ccc(F)cc3F)ccc2CCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.49
GSK3B P49841 2/20 0.46
BACE1 P56817 2/20 0.46
FFAR4 Q5NUL3 7/20 0.45
PTGER1 P34995 3/20 0.45
PPARA Q07869 1/20 0.44
RXRB P28702 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
RXRA P19793 2/20 0.43
RXRG P48443 2/20 0.43
ALKBH1 Q13686 1/20 0.43
POLB P06746 1/20 0.41
GFER P55789 1/20 0.41
PAX8 Q06710 1/20 0.41
KLF5 Q13887 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7215867 0.88 MAOB (0.49) MAOBGSK3BBACE1FFAR4PTGER1
SCHEMBL7218008 0.85 RXRB (0.57) MAOBRXRBNPC1RAB9ARXRA
SCHEMBL7216413 0.83 NPC1 (0.46) MAOBRXRBNPC1RAB9ARXRA
SCHEMBL7216359 0.80 NPC1 (0.56) MAOBRXRBNPC1RAB9ARXRA
SCHEMBL7222242 0.77 MAOB (0.57) MAOBRXRBNPC1RAB9ARXRA
SCHEMBL7216468 0.77 RXRB (0.47) MAOBFFAR4PPARARXRBNPC1
SCHEMBL7222385 0.76 NPC1 (0.55) MAOBFFAR4RXRBNPC1RAB9A
SCHEMBL7222036 0.76 NPC1 (0.55) MAOBRXRBNPC1RAB9ARXRA
SCHEMBL7218088 0.74 PARP10 (0.46) MAOBRXRBNPC1RAB9ARXRA
SCHEMBL7222742 0.73 MAOB (0.52) MAOBRXRBNPC1RAB9ARXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed